QuickBird Medical
  • German
  • Case Studies
    • Case Studies
    • Customers
  • Services
    • Development: DiGA
    • Development: Medical Software – EU & MDR
    • Development: Medical Software – US & FDA
    • Embedded Software
    • Development: Wearables for Medical Devices
    • Development: Decision Support Systems
    • Development: Medical AI Systems
    • Legal Manufacturer for Medical Devices
    • Further Services
  • Insights
  • About Us
    • Company
    • Team
    • Jobs
    • Certifications
  • Contact
Select Page
← to the overview of all news

AI Act: Ban on Prohibited Practices Takes Effect

February 12, 2025

The AI Act is entering into force in stages: since February 2, the use of prohibited practices has been ruled out. What exactly these prohibited practices are is explained by the EU Commission across 140 pages of guidelines.

AI Act - What Happens Next

If you are interested in the AI Act, also read our updated expert article: AI Act: A Guide for Medical Device Manufacturers under the MDR (2025).


Are you planning to implement medical software
or DiGA?

Contact us for a free initial consultation. We will give you an estimate of the effort and timeframe required to implement your project. We will also examine the regulatory and strategic framework conditions for your product.

Contact us
Contact

+49 (0) 89 54998380
contact@quickbirdmedical.com

Whitepaper

13 important recommendations for prospective DiGA manufacturers in 2026

13 important recommendations for prospective medical device manufacturers in 2026

Current

DiGA and Medical Software Newsletter

Digital Health Events 2026

Press – QuickBird in the Media

© 2026 Imprint | Data Policy